SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2021 OR ☐ Transition Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 COMMISSION FILE NUMBER 001-38661 Elanco Animal Health Incorporated (Exact name of Registrant as specified in its charter) INDIANA 82-5497352 (State or other jurisdiction of (I.R.S. Employer incorporation or organizat ...

Elanco Animal Health Incorporated (NYSE:ELAN) Q2 2021 Earnings Conference Call August 9, 2021 8:00 AM ET Company Participants Tiffany Kanaga - Investor Relations Jeff Simmons - President & Chief Executive Officer Todd Young - Chief Financial Officer Conference Call Participants Jon Block - Stifel Elliot Wilbur - Raymond James Michael Ryskin - Bank of America Nathan Rich - Goldman Sachs Umer Raffat - Evercore ISI Balaji Prasad - Barclays Operator Ladies and gentleman, thank you for standing by, and welcome t ...

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2021 OR ☐ Transition Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 COMMISSION FILE NUMBER 001-38661 Elanco Animal Health Incorporated (Exact name of Registrant as specified in its charter) INDIANA 82-5497352 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) ...

Kindred Biosciences, Inc. (KIN) Q1 2021 Results Conference Call May 11, 2021 4:30 PM ET Company Participants Dr. Richard Chin - CEO Wendy Wee - CFO Katja Buhrer - VP of Corporate Development and IR Conference Call Participants Trevor Brown - Stifel Ben Haynor - Alliance Global Balaji Prasad - Barclays Brandon Folkes - Cantor Fitzgerald John Lee - H.C. Wainwright David Westenberg - Guggenheim Securities Operator Welcome to the First Quarter 2021 Financial Results Conference Call and Webcast for Kindred Biosc ...

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2021 OR ☐ Transition Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 COMMISSION FILE NUMBER 001-38661 Elanco Animal Health Incorporated (Exact name of Registrant as specified in its charter) INDIANA 82-5497352 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) ...

Kindred Biosciences, Inc. (KIN) Q4 2020 Earnings Conference Call March 16, 2021 4:30 PM ET Company Participants Richard Chin - CEO Wendy Wee - CFO Katja Buhrer - VP of Corporate Development and IR Conference Call Participants Jon Block - Stifel Brooks O'Neil - Lake Street Capital Brandon Folkes - Cantor Fitzgerald Swayampakula Ramakanth - H.C. Wainwright Operator Welcome to the Fourth Quarter and Full Year 2020 Financial Results Conference Call and Webcast for Kindred Biosciences. At this time, all particip ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, no par value ELAN New York Stock Exchange 5.00% Tangible Equity Units ELAT New York Stock Exchange Form 10-K ANNUAL REPORT UNDER SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 Commission file number 001-38661 Elanco Animal Health Incorporated (Exact name of Registrant as specified in its c ...

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2020 OR ☐ Transition Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 COMMISSION FILE NUMBER 001-38661 Elanco Animal Health Incorporated (Exact name of Registrant as specified in its charter) INDIANA 82-5497352 (State or other jurisdiction of (I.R.S. Employer incorporation or organizat ...

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Common stock, no par value ELAN New York Stock Exchange 5.00% Tangible Equity Units ELAT New York Stock Exchange Form 10-Q ☒ Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2020 OR ☐ Transition Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 COMMISSION FILE NUMBER 001-3 ...

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Common stock, no par value ELAN New York Stock Exchange 5.00% Tangible Equity Units ELAT New York Stock Exchange Form 10-Q ☒ Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2020 OR ☐ Transition Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 COMMISSION FILE NUMBER 001- ...